Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection

INTRODUCTION: Conbercept is a new anti-vascular endothelial growth factor drug approved for the treatment of age-related macular degeneration by the China Food and Drug Administration (CFDA) in 2013. In this study, we for the first time evaluated the concentrations of vascular endothelial growth fac...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jun, Liu, Zheng, Chen, Meng, Luo, Zhi-Heng, Li, Yun-Qiu, Qi, Guang-Ying, Liu, Tao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250636/
https://www.ncbi.nlm.nih.gov/pubmed/30377995
http://dx.doi.org/10.1007/s13300-018-0527-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250636/
https://www.ncbi.nlm.nih.gov/pubmed/30377995
http://dx.doi.org/10.1007/s13300-018-0527-9

Ejemplares similares